InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-50.5%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Donenberg Phillip B., 董事. Officer active across 2 companies, notably Taysha Gene Therapies, Inc.. Cumulatively, 4 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €113k. History available since 2 February 2022. The latest transaction was filed on 2 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Donenberg Phillip B.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
56,623 股0Common StockSEC:0001415889-25-015573:0
49,220 股0Common StockSEC:0001415889-24-015039:0
111,111 股@ US$0.9069.0% 占其流量Common StockSEC:0001209191-23-046148:0
标准退出：2023年11月14日 (T+90)
3,000 股@ US$7.7818.4% 占其流量Common StockSEC:0001209191-22-006641:0
标准退出：2022年5月3日 (T+90)
4 条申报中的 4 条
About Donenberg Phillip B.
Phillip B. Donenberg is a Board Member of Taysha Gene Therapies, Inc. In this role, he brings his expertise in corporate governance and financial strategy. Phillip is involved in overseeing operations and strategic decisions that influence the company's performance. His experience in the biopharmaceutical sector is a valuable asset to the board.
